Basic Information
| LncRNA/CircRNA Name | MIR210HG |
| Synonyms | uc009yby.1 |
| Region | GRCh38_11:565660-568457 |
| Ensemble | ENSG00000247095 |
| Refseq | NR_038262 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | Microarray, qPCR etc. |
| Sample | blood, glioma tissues |
| Expression Pattern | up-regulated |
| Function Description | MIR210HG levels were significantly higher in tumor tissue than in tumor-adjacent normal tissue in participating glioma patients. Serum miR210HG levels were also significantly higher in glioma patients than in healthy controls. |
| Pubmed ID | 27673330 |
| Year | 2016 |
| Title | Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma. |
External Links
| Links for MIR210HG | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |